LEHI If given a chance, who wouldnt want to spend a few bucks to find out if theyre at heightened risk for one day having to confront some life-changing or life-ending medical malady?
Thats the concept fueling an explosion in direct-to-consumer genetic testing and one thats also elevating ethical debates about how this most personal of information should be interpreted and protected.
Utah-born Ancestry.com is the latest entry into a growing list of companies offering health-focused genetic testing an industry expected to grow to $20 billion annually in the next few years.
While best known and an industry leader for its expertise in providing answers to the Where am I from? question, Ancestry will now expand its genetic testing resources to help people anticipate future health issues and help address, Whats going to make me sick?
Last week, the company that launched more than 30 years ago as a family history search service, later adding DNA testing to help customers identify their geographic ancestral roots, announced its new, health-focused genetic testing service.
AncestryHealth will offer two levels of genetic testing that the company said will deliver actionable insights that can empower people to take proactive steps in collaboration with their health care provider to address potential health risks identified in their genes and family health history.
Ancestry CEO Margo Georgiadis said the new genetic tests will help clients proactively manage their health care needs, armed with new insight on what conditions they may be predisposed for, based on genetic evidence.
Your genes dont need to be your destiny, Georgiadis said in a statement. Understanding your familial and inherited health risks can help you take action with your doctor to improve your chances of better health outcomes.
For more than three decades, Ancestry has empowered journeys of personal discovery to enrich lives. In the same way that knowledge of your family and ethnicity helps you understand your past to inspire your future, knowledge of your genetic health profile and any associated risks can help you be proactive in managing the future for you and your family.
The two testing products, according to the company, include AncestryHealth Core, which uses the companys current genotype genetic assessment technique to detect genetic differences and deliver personalized reports related to health conditions such as heart disease, hereditary cancers, blood-related disorders, and risks for carrier status of health conditions, such as Tay-Sachs disease. The one-time test costs $149 and also includes the companys family history report. Those who have already submitted a biologic sample to the company can get the new genetic report for $49.
While likely not available until sometime in 2020, the AncestryHealth Plus will use more current, genetic sequencing technology that will provide greater coverage of DNA differences for each condition and more risk categories such as those related to potentially developing heart disease, cancers, and disorders related to blood, the nervous system and connective tissues. The sequencing test will require a $199 activation fee, which the company said includes the first six months of membership and an additional $49 membership fee every six months. Existing Ancestry customers will be able to upgrade to AncestryHealth Plus for an initial payment of $49.
Ancestrys testing regimen will assess genetic samples and indicate predispositions for high cholesterol and cardiomyopathy, which can lead to heart disease; hereditary indicators for breast, ovarian, colon and uterine cancers; and blood disorders including abnormal clotting and iron overload. The testing can also determine if the sample donor is a gene carrier for cystic fibrosis, sickle-cell anemia or Tay-Sachs disease, a fatal nervous system disorder that most commonly occurs in children.
Unlike its competitor, 23andMe, which has earned U.S. Food and Drug Administration approval for providing genetic test results directly to customers without a physicians participation, Ancestrys genetic testing service requires a physicians order to conduct the tests and the company says it has contracted with a private network of independent physicians and genetic counselors who participate in the process. Ancestrys health testing service also connects customers to educational information, including access to genetic counseling resources and provides printable and consumer and physician-ready reports that provide guidance for next steps an individual and their health care provider can take together.
Lynn Jorde, chairman of the University of Utahs Department of Human Genetics and executive director of the Utah Genome Project, said while labs are now capable of sequencing the entirety of the human genome some 3 billion genetic basis pairs the microarray technique currently used by Ancestry evaluates a small window of genes that, if a variation is found, have a viable medical response.
What theyre looking at is specific changes in the DNA that we know about in specific instances ... and are often called actionable genes, Jorde explained. If you have a disease causing variant here, there is actually something we can do about it.
Jorde said while some genetic markers, like those for cystic fibrosis, indicate a high probability that you have or will develop that condition, many more are merely suggestive.
The predictive power of genetic testing is getting better and better, but it will never be perfect, Jorde said. For many of these conditions, there are nongenetic components that impact risk.
Jorde said things like environment, diet and exercise/activity level can play a significant role in an individuals risk of developing an illness or disease.
Teneille Brown is a professor at the University of Utahs S.J. Quinney College of Law and an expert in health law and medical ethics. In an interview, she noted direct-to-consumer genetic testing services, now being offered by dozens of companies according to the National Institute of Health, are occupying a space thats in between current regulatory boundaries aimed at protecting individuals privacy rights.
In the research realm, any federally funded projects are subject to stringent privacy rules, Brown said. That is also the case for health care institutions that handle genetic material, under (Health Insurance Portability and Accountability Act) rules.
But the big databases being built by testing companies are outside of the federal funding process and are not health care providers, so the HIPAA rules dont apply, Brown said.
Ancestry appears to underscore this by noting, in its user agreement, that it is not a covered entity under HIPAA rules.
Brown noted that in addition to unanswered questions about privacy protections, genetic test results can lead to deep emotional impacts for tested individuals, either through the discovery of gene markers that are suggestive of some future medical challenge or, less obviously, when a clean test is returned, which may provide an inaccurate suggestion that theres nothing to worry about.
Theres a huge problem when it comes to understanding what these risk scores mean, Brown said. The predictive values of these results is widely variable, including what is, or is not, implied by failure to find a specific marker.
Brown said genetic testing companies have wide-ranging policies regarding sharing an individuals genetic test results or stored biologic samples with third-party researchers. Ancestry, for example, says it will only share your information if youve given them specific permission to do so, through its informed consent agreement.
While the regulatory world is lagging behind the fast-moving development of genetic testing technology, Brown said she believes the bigger companies, including Ancestry, are working to create appropriate protections for their customers. And, she added, the growing body of knowledge being accumulated by this work could lead to groundbreaking advancements in treatments for serious diseases.
These companies might play a role in developing amazing drugs and therapies, Brown said. Collectively, they are adding all of this amazing content, providing pedigrees and information and incredibly powerful databases ... and a lot of good can come of it.
Its not at all sinister, but we need consumers to know what theyre submitting and being diligent about potential secondary uses of that data. More robust consent requirements for users and strict limitations for secondary uses are certainly in order.
- Human Genetics Market 2020: Challenges, Growth, Types, Applications, Revenue, Insights, Growth Analysis, Competitive Landscape, Forecast- 2025 - Cole... - June 30th, 2020
- Race Is Real, But It's Not Genetic - Discover Magazine - June 30th, 2020
- deCODE Genetics: Loss of Function Variant in FLT3 Strongly Increases the Risk of Autoimmune Thyroid Disease and Other Autoimmune Diseases - Yahoo... - June 30th, 2020
- Scientists and Societies Decry Trump Executive Order on Immigration Visas - Genetic Engineering & Biotechnology News - June 30th, 2020
- Seattle Genetics Announces Positive Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer -... - June 30th, 2020
- Unpicking the complexity of DNA mutations - Cambridge Network - June 30th, 2020
- And finally... Where there's muck, there's brass - Scottish Construction Now - June 30th, 2020
- Cause of Common Autoinflammatory Disease May Have Protected Ancestors From Plague - Technology Networks - June 30th, 2020
- Human Genetics Market Analysis with Key Players, Applications, Trends and Forecasts to 2026 - Farmers Ledger - June 24th, 2020
- Building Genetic Diversity Into Cancer Research - Cancer Health Treatment News - June 24th, 2020
- Drugging the Undruggable: How AI Does the (Almost) Impossible - BioSpace - June 24th, 2020
- Seven Bridges Expands Its Pioneering Graph-Based Offerings to Advance Important Human Genome Research - P&T Community - June 24th, 2020
- Exposure and engagement with tobacco-related social media and associations with subsequent tobacco use among young adults: A longitudinal analysis. -... - June 24th, 2020
- Coronavirus news and updates: Does Florida's spike in cases make it a new 'epicenter'?; mask rules on airplanes from the FAA - USA TODAY - June 24th, 2020
- COVID-19 Test Samples: Why Do We Swab Instead of Spit? - The Wire - June 24th, 2020
- Friedrich Miescher gets ahead of the double helix - Cosmos - May 24th, 2020
- Enhancing food diversity in the midst of a climate crisis: How plant genetic material ensures future food security - Kenya - ReliefWeb - May 24th, 2020
- Data Reveals DNA Variations that Alter Breast Cancer Risk in Women - Cancer Network - May 24th, 2020
- What the genetics of COVID-19 mean for the survival of wild great apes - Landscape News - May 24th, 2020
- Coronavirus: BAME deaths urgently need to be understood, including any potential genetic component - The Conversation UK - May 24th, 2020
- How to live to 100 - Business Times - May 24th, 2020
- How Ancient Fossil DNA Reveals the Secrets of Our Human Origins - Ancient Origins - May 24th, 2020
- Covid-19 versus genomics and other advanced technologies - E&T Magazine - May 24th, 2020
- Seattle Genetics Announces the Approval of TUKYSA (tucatinib) in Switzerland for the Treatment of Patients with Metastatic HER2-Positive Breast Cancer... - May 12th, 2020
- Scientists concerned that coronavirus is adapting to humans - The Guardian - May 11th, 2020
- Yes, COVID-19 is mutating, here's what you need to know - ABC News - May 11th, 2020
- DNA of Bones Found in Cave Reveals Major Cultural Transition in Europe Took Place Earlier Than Thought - SciTechDaily - May 11th, 2020
- Conservatives Are Not the Only Ones Who Ignore Facts and the Science - Merion West - May 11th, 2020
- Dr. Misaki Wayengera: The Man Behind Uganda's Covid 19 Test Kits - New Vision - May 11th, 2020
- Its In The Genes? Scientists Think Coronavirus Exploits Silent Hidden Mutations In The Body - International Business Times - May 11th, 2020
- MET 2020 Slot booking to commence on July 15, Examination dates available at manipal.edu - Jagran Josh - May 11th, 2020
- From blood clots to 'Covid toe': Experts confounded by series of medical mysteries - The Straits Times - May 11th, 2020
- Wuhan lab says there's no way coronavirus originated there. Here's the science. - Livescience.com - April 18th, 2020
- New study suggests COVID-19 hopped from dogs to humans. Here's why you should be skeptical. - Live Science - April 18th, 2020
- University of Washington to study COVID-19 pharmacogenetics - ModernHealthcare.com - April 18th, 2020
- Visiongain Report: The Gene Therapy Market is Projected to Grow at a CAGR of 32% in the First Half of the Forecast Period - Yahoo Finance - April 18th, 2020
- Vanda Pharmaceuticals Announces Initiation of "CALYPSO" to Study the Role of Genetic Variation in COVID-19 Infections in Collaboration With... - April 18th, 2020
- Genomic mapping in outbred mice reveals overlap in genetic susceptibility for HZE ion and -rayinduced tumors - Science Advances - April 18th, 2020
- Axovant Announces Partnership with Invitae to Increase Access to Genetic Testing and Accelerate Diagnoses of GM1 and GM2 Gangliosidosis -... - April 18th, 2020
- Community resilience is facing Its greatest threat, and colleges are helping | Opinion - pennlive.com - April 18th, 2020
- Iceland Provides a Picture of the Early Spread of COVID-19 in a Population With a Cohesive Public Health Response - WFMZ Allentown - April 18th, 2020
- Stem Cells and Silk Make a New Way to Study the Brain - Tufts Now - April 18th, 2020
- NJ Site First In U.S. To Offer Drive-Thru Coronavirus Saliva Test - Patch.com - April 18th, 2020
- Any Good News on Coronavirus This Week? Actually, Yes - Yahoo Finance - April 18th, 2020
- The PBS documentary The Gene showcases genetics promise and pitfalls - Science News - April 9th, 2020
- Few clinical trials are done in Africa: COVID-19 shows why this urgently needs to change - The Conversation Africa - April 9th, 2020
- UCLA web app will enlist publics help in slowing the spread of COVID-19 - Newswise - April 9th, 2020
- Why does the new coronavirus kill some people and barely affect others? - Wilkes-Barre Citizens Voice - April 9th, 2020
- 'Behavioral suppression' needed to decrease coronavirus infections in Japan: experts - The Mainichi - April 9th, 2020
- COVID-19: Few Clinical Trials are Done in Africa. This Needs to Change ASAP. - The Wire - April 9th, 2020
- The secret call of the wild: how animals teach each other to survive - The Guardian - April 9th, 2020
- Study suggests humans transported badgers from Britain to Ireland - Agriland - April 7th, 2020
- Indians do not have genetic protection against coronavirus, published research incorrectly interpreted - Alt News - April 7th, 2020
- How sick will the coronavirus make you? The answer may be in your genes - Science Magazine - March 31st, 2020
- BHU department claims to have discovered new technology to test COVID-19 - Jagran Josh - March 31st, 2020
- Unlocking the Genetic Code of the Novel Coronavirus: How COVID-19 Made the Leap From Animals to Humans - SciTechDaily - March 31st, 2020
- Q2 Solutions, an IQVIA and Quest Diagnostics Joint Venture, Collaborates with University of Texas Medical Branch to Help Accelerate Development of... - March 31st, 2020
- Icelandic Researchers Discover Origin of New Birch Forest - IcelandReview - March 31st, 2020
- Coronavirus threatens other areas of scientific progress, researchers fear - CNN - March 31st, 2020
- The perfect virus: two gene tweaks that turned COVID-19 into a killer - Sydney Morning Herald - March 31st, 2020
- The race to find the coronavirus cure - British GQ - March 31st, 2020
- 2020 Canada Gairdner Awards Recognize World-renowned Scientists for Transformative Contributions to Research That Impact Human Health - Yahoo Finance - March 31st, 2020
- Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis - P&T... - March 26th, 2020
- The Coronavirus Pandemic Shows Us The Importance Of Combatting Climate Change - Forbes - March 26th, 2020
- IN CONSERVATION: DR. JEFF STROVEL, CEO of VERALOX THERAPEUTICS - BioBuzz - March 26th, 2020
- The genetic architecture of the human cerebral cortex - Science Magazine - March 24th, 2020
- Avera announces ability to test for COVID-19 in South Dakota - The Dickinson Press - March 24th, 2020
- University of Utah experts advise caution over drugs hyped as possible coronavirus treatments - Salt Lake Tribune - March 24th, 2020
- Studying the African genome could yield new medical treatments for everyone - Genetic Literacy Project - March 24th, 2020
- Coronavirus: Massive gap in US response revealed after scientists learn colleague tested positive through twee - MEAWW - March 24th, 2020
- Scientist Who Discovered BRCA1 Gene to Give Free Talk on Cancer And Genetics - Noozhawk - January 18th, 2020
- Hackensack Meridian Health Center for Discovery and Innovation to Host Genomic Medicine Symposium - P&T Community - January 18th, 2020
- Do genetic ancestry tests know if you're Palestinian? A cautionary tale of race and science - ABC News - January 18th, 2020
- Genetic testing firm 23andMe is first to create a drug using its customers' DNA - The Times - January 18th, 2020
- 11 Year-Old Bertrand Might Cant Cry Scientists Have Now Discovered Why - SciTechDaily - January 18th, 2020
- Why Cant Bertrand Might Cry? Missing Water Channels Could Be the Answer - Technology Networks - January 18th, 2020
- Controlling Our Own Evolution: What is the Future of Gene-Editing? - The Globe Post - January 18th, 2020
- There is a new player in adult bone healing - Baylor College of Medicine News - January 18th, 2020
- Ancient Hominids May Have Helped Protect Humans From Malaria - Newsweek - January 18th, 2020
- Drugs from nature: Researchers from U of T, Japan mine microbial compound library for new therapeutics - News@UofT - January 18th, 2020